Purchases and Sales Made in Q4 2022 in Kiromic Biopharma, Inc. (KRBP)
This table provides information about the institutional ownership of Kiromic Biopharma, Inc. (KRBP) during Q4 2022. The information is specifically focused on institutions that hold shares of Kiromic Biopharma, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2023
Q4 2022
|
Sabby Management, LLC
Upper Saddle River, NJ |
BUY
|
- |
550KNew |
$88K - $6.47M
|
550K
$770K
|
|
|
Feb 15, 2023
Q4 2022
|
Virtu Financial LLC
New York, NY |
BUY
|
- |
31.8KNew |
$5.09K - $374K
|
31.8K
$44.5K
|
|
|
Feb 08, 2023
Q4 2022
|
Ubs Group Ag
|
BUY
|
- |
20.2K+ 109.38% |
$3.24K - $238K
|
38.8K
$54.3K
|
|
|
Feb 14, 2023
Q4 2022
|
Morgan Stanley
New York, NY |
BUY
|
- |
6+ 0.5% |
$0.96 - $70.6
|
1.21K
$1.69K
|
|
|
Feb 13, 2023
Q4 2022
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
2+ 2.67% |
$0.32 - $23.5
|
77
$108
|
|
|
Jan 30, 2023
Q4 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 10, 2023
Q4 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-199- 4.08% |
$31.8 - $2.34K
|
4.68K
$6.55K
|